1. Home
  2. IGIC vs MRVI Comparison

IGIC vs MRVI Comparison

Compare IGIC & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International General Insurance Holdings Ltd.

IGIC

International General Insurance Holdings Ltd.

SELL

Current Price

$24.50

Market Cap

1.2B

Sector

Finance

ML Signal

SELL

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

SELL

Current Price

$6.57

Market Cap

1.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
IGIC
MRVI
Founded
2001
2014
Country
Jordan
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
IGIC
MRVI
Price
$24.50
$6.57
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
★ $31.00
$7.83
AVG Volume (30 Days)
90.9K
★ 2.2M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
★ 5.88%
N/A
EPS Growth
N/A
★ 14.29
EPS
★ N/A
N/A
Revenue
N/A
★ $185,743,000.00
Revenue This Year
$4.98
$14.01
Revenue Next Year
$2.89
$6.20
P/E Ratio
$9.05
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$20.82
$2.55
52 Week High
$29.59
$9.42

Technical Indicators

Market Signals
Indicator
IGIC
MRVI
Relative Strength Index (RSI) 40.32 40.52
Support Level $24.34 $6.49
Resistance Level $26.04 $7.60
Average True Range (ATR) 0.47 0.43
MACD 0.07 -0.11
Stochastic Oscillator 46.30 0.48

Price Performance

Historical Comparison
IGIC
MRVI

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialty insurance and reinsurance group. It underwrites a diversified portfolio of specialty risks including energy, property, construction and engineering, ports and terminals, general aviation, political violence, professional lines, financial institutions, marine, contingency and treaty reinsurance. The company's operating segments include Specialty Longtail, Specialty Short tail and Reinsurance. The majority of revenue is derived from the Specialty Short-tail segment, which comprises business lines with underwriting risks assumed in the form of property and specialty lines insurance and of short-term nature with respect to related claims.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: